Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Isatuximab-irfc

(I-suh-TUK-sih-mab)

This page contains brief information about isatuximab-irfc and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Sarclisa
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Isatuximab-irfc is approved to treat:

Isatuximab-irfc is also being studied in the treatment of other types of cancer.

More About Isatuximab-irfc

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Isatuximab-irfc - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: